{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:37:25Z","timestamp":1790699845479,"version":"4.1.0"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005902","name":"Institute for Clinical and Translational Research, University of Wisconsin, Madison","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005902","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006380","name":"Rehabilitation Research and Development Service","doi-asserted-by":"publisher","award":["101RX001030"],"award-info":[{"award-number":["101RX001030"]}],"id":[{"id":"10.13039\/100006380","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01DK107007-01A1"],"award-info":[{"award-number":["1R01DK107007-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001583","name":"Diabetes Action Research and Education Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001583","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["autonomicneuroscience.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autonomic Neuroscience"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.autneu.2020.102722","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T11:51:47Z","timestamp":1599825107000},"page":"102722","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Is there cardiac autonomic neuropathy in prediabetes?"],"prefix":"10.1016","volume":"229","author":[{"given":"Lindsay A.","family":"Zilliox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autneu.2020.102722_bb0005","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2337\/dc05-2179","article-title":"Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose","volume":"29","author":"Abdul-Ghani","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.autneu.2020.102722_bb0010","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet. Med."},{"key":"10.1016\/j.autneu.2020.102722_bb0015","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc18-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018","volume":"41","author":"American Diabetes, A","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.autneu.2020.102722_bb0020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02629130","article-title":"The relationship between blood glucose concentration and beat-to-beat variation in asymptomatic subjects","volume":"20","author":"Annuzzi","year":"1983","journal-title":"Acta Diabetol. Lat."},{"key":"10.1016\/j.autneu.2020.102722_bb0025","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.2337\/diab.45.10.1289","article-title":"The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial","volume":"45","author":"Anon","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.autneu.2020.102722_bb0030","first-page":"873","article-title":"Assessment: clinical autonomic testing report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"46","author":"Anon","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.autneu.2020.102722_bb0035","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2337\/diacare.20.7.1183","article-title":"Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus [see comments]","volume":"20","author":"Anon","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.autneu.2020.102722_bb0040","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.2337\/diacare.23.11.1619","article-title":"The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group","volume":"23","author":"Anon","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.autneu.2020.102722_bb0045","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2337\/dc11-1468","article-title":"The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP\/DPPOS","volume":"35","author":"Anon","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.autneu.2020.102722_bb0050","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1007\/s00125-004-1574-5","article-title":"Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study","volume":"47","author":"Balkau","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.autneu.2020.102722_bb0055","doi-asserted-by":"crossref","first-page":"16H","DOI":"10.1016\/S0002-9149(01)01832-X","article-title":"Impaired glucose tolerance as a disease","volume":"88","author":"Baron","year":"2001","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.autneu.2020.102722_bb0060","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00125-015-3538-3","article-title":"Upper gastrointestinal motility and symptoms in individuals with diabetes, prediabetes and normal glucose tolerance","volume":"58","author":"Boronikolos","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.autneu.2020.102722_bb0065","doi-asserted-by":"crossref","first-page":"914","DOI":"10.2337\/diacare.29.04.06.dc05-1729","article-title":"The association among autonomic nervous system function, incident diabetes, and intervention arm in the diabetes prevention program","volume":"29","author":"Carnethon","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.autneu.2020.102722_bb0070","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.2337\/diacare.26.5.1333","article-title":"The significance of impaired fasting glucose versus impaired glucose tolerance: importance of insulin secretion and resistance","volume":"26","author":"Carnevale Schianca","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.autneu.2020.102722_bb0075","series-title":"National Diabetes Statistics Report","volume":"vol. 2017","author":"CDC","year":"2017"},{"key":"10.1016\/j.autneu.2020.102722_bb0080","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/bs.irn.2019.04.002","article-title":"Role of mitochondria in diabetic peripheral neuropathy: influencing the NAD(+)-dependent SIRT1-PGC-1alpha-TFAM pathway","volume":"145","author":"Chandrasekaran","year":"2019","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.autneu.2020.102722_bb0085","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/(SICI)1097-4598(199801)21:1<72::AID-MUS10>3.0.CO;2-2","article-title":"Risks for sensorimotor peripheral neuropathy and autonomic neuropathy in non-insulin-dependent diabetes mellitus (NIDDM)","volume":"21","author":"Cohen","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autneu.2020.102722_bb0090","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2337\/dc06-0062","article-title":"Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999\u20132002","volume":"29","author":"Cowie","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.autneu.2020.102722_bb0095","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jdiacomp.2016.11.002","article-title":"Risk factors for autonomic and somatic nerve dysfunction in different stages of glucose tolerance","volume":"31","author":"Dimova","year":"2017","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.autneu.2020.102722_bb0100","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1464-5491.2010.03221.x","article-title":"Cardiovascular autonomic neuropathy contributes to left ventricular diastolic dysfunction in subjects with type 2 diabetes and impaired glucose tolerance undergoing coronary angiography","volume":"28","author":"Dinh","year":"2011","journal-title":"Diabet. Med."},{"key":"10.1016\/j.autneu.2020.102722_bb0105","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1529-8027.2012.00420.x","article-title":"Prediabetes\/early diabetes-associated neuropathy predominantly involves sensory small fibres","volume":"17","author":"Divisova","year":"2012","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.autneu.2020.102722_bb0110","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/oxfordjournals.aje.a115547","article-title":"Sensory neuropathy in non-insulin-dependent diabetes mellitus. The San Luis Valley Diabetes Study","volume":"131","author":"Franklin","year":"1990","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.autneu.2020.102722_bb0115","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/archneur.1991.00530140079020","article-title":"Spectral analysis of heart rate in diabetic autonomic neuropathy. A comparison with standard tests of autonomic function","volume":"48","author":"Freeman","year":"1991","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.autneu.2020.102722_bb0120","doi-asserted-by":"crossref","first-page":"730","DOI":"10.2337\/diab.36.6.730","article-title":"Prevalence of complications among second-generation Japanese-American men with diabetes, impaired glucose tolerance, or normal glucose tolerance","volume":"36","author":"Fujimoto","year":"1987","journal-title":"Diabetes"},{"key":"10.1016\/j.autneu.2020.102722_bb0125","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"Gaede","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.autneu.2020.102722_bb0130","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2362.2007.01752.x","article-title":"Impaired cardiac autonomic function in women with prior gestational diabetes mellitus","volume":"37","author":"Gasic","year":"2007","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.autneu.2020.102722_bb0135","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.2337\/diacare.26.11.3160","article-title":"Follow-up report on the diagnosis of diabetes mellitus","volume":"26","author":"Genuth","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.autneu.2020.102722_bb0140","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s001250051344","article-title":"Glucose tolerance and other determinants of cardiovascular autonomic function: the Hoorn Study","volume":"43","author":"Gerritsen","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.autneu.2020.102722_bb0145","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10286-007-0426-z","article-title":"Impaired glucose tolerance is associated with postganglionic sudomotor impairment","volume":"17","author":"Grandinetti","year":"2007","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.autneu.2020.102722_bb0150","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2337\/dc09-0101","article-title":"Altered C-fiber function as an indicator of early peripheral neuropathy in individuals with impaired glucose tolerance","volume":"33","author":"Green","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.autneu.2020.102722_bb0155","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s001250050924","article-title":"The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT)","volume":"41","author":"Group, T.D.C.a.C.T.R","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/j.autneu.2020.102722_bb0160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.freeradbiomed.2005.04.002","article-title":"Exercise training and the antioxidant alpha-lipoic acid in the treatment of insulin resistance and type 2 diabetes","volume":"40","author":"Henriksen","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.autneu.2020.102722_bb0165","series-title":"IDF Diabetes Atlas, International Diabetes Federation","first-page":"1","volume":"vol. 7","author":"IDF","year":"2015"},{"key":"10.1016\/j.autneu.2020.102722_bb0170","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/dmrr.859","article-title":"Evaluation of peripheral and autonomic neuropathy among patients with newly diagnosed impaired glucose tolerance","volume":"24","author":"Isak","year":"2008","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.autneu.2020.102722_bb0175","doi-asserted-by":"crossref","first-page":"656","DOI":"10.4103\/0028-3886.149393","article-title":"Prevalence of neuropathy in patients with impaired glucose tolerance using various electrophysiological tests","volume":"62","author":"Kannan","year":"2014","journal-title":"Neurol. India"},{"key":"10.1016\/j.autneu.2020.102722_bb0180","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/01.ATV.20.3.823","article-title":"Diabetes mellitus: subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality","volume":"20","author":"Kuller","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.autneu.2020.102722_bb0185","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1464-5491.2011.03278.x","article-title":"Cardiovascular autonomic dysfunction is associated with central obesity in persons with impaired glucose tolerance","volume":"28","author":"Laitinen","year":"2011","journal-title":"Diabet. Med."},{"key":"10.1016\/j.autneu.2020.102722_bb0190","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1001\/archinte.164.19.2147","article-title":"Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies","volume":"164","author":"Levitan","year":"2004","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.autneu.2020.102722_bb0195","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jacc.2007.09.038","article-title":"Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study","volume":"51","author":"Levitzky","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.autneu.2020.102722_bb0200","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.expneurol.2012.11.001","article-title":"Endoplasmic reticulum stress contributes to prediabetic peripheral neuropathy","volume":"247","author":"Lupachyk","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.autneu.2020.102722_bb0205","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/1476-511X-10-217","article-title":"Effect of alpha-lipoic acid and exercise training on cardiovascular disease risk in obesity with impaired glucose tolerance","volume":"10","author":"McNeilly","year":"2011","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.autneu.2020.102722_bb0210","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.2337\/diacare.25.10.1845","article-title":"Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study","volume":"25","author":"Meigs","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.autneu.2020.102722_bb0215","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2337\/dc07-9920","article-title":"Impaired fasting glucose and impaired glucose tolerance: implications for care","volume":"30","author":"Nathan","year":"2007","journal-title":"Diabetes Care"},{"issue":"Suppl. 5A","key":"10.1016\/j.autneu.2020.102722_bb0220","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1016\/j.amjmed.2003.10.016","article-title":"Correlation between cardiovascular disease and diabetes mellitus: current concepts","volume":"116","author":"Nesto","year":"2004","journal-title":"Am. J. Med."},{"key":"10.1016\/j.autneu.2020.102722_bb0225","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.2337\/dc09-2328","article-title":"Cardiovascular disease mortality in Europeans in relation to fasting and 2-h plasma glucose levels within a normoglycemic range","volume":"33","author":"Ning","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.autneu.2020.102722_bb0230","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fendo.2017.00129","article-title":"Increased short-term beat-to-beat QT interval variability in patients with impaired glucose tolerance","volume":"8","author":"Orosz","year":"2017","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.autneu.2020.102722_bb0235","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2337\/diabetes.51.3.803","article-title":"Association of fasting plasma glucose with heart rate recovery in healthy adults: a population-based study","volume":"51","author":"Panzer","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.autneu.2020.102722_bb0240","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.sleep.2006.06.010","article-title":"Autonomic dysfunction in obstructive sleep apnea is associated with impaired glucose regulation","volume":"8","author":"Peltier","year":"2007","journal-title":"Sleep Med."},{"key":"10.1016\/j.autneu.2020.102722_bb0245","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/mus.21210","article-title":"Reliability of quantitative sudomotor axon reflex testing and quantitative sensory testing in neuropathy of impaired glucose regulation","volume":"39","author":"Peltier","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autneu.2020.102722_bb0250","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2261-6-19","article-title":"Circadian rhythm of the autonomic nervous system in insulin resistant subjects with normoglycemia, impaired fasting glycemia, impaired glucose tolerance, type 2 diabetes mellitus","volume":"6","author":"Perciaccante","year":"2006","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.autneu.2020.102722_bb0255","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2337\/dc09-1294","article-title":"Cardiac autonomic neuropathy in diabetes: a clinical perspective","volume":"33","author":"Pop-Busui","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.autneu.2020.102722_bb0260","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1161\/CIRCULATIONAHA.108.837369","article-title":"Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications study (DCCT\/EDIC)","volume":"119","author":"Pop-Busui","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.autneu.2020.102722_bb0265","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2337\/dc16-2042","article-title":"Diabetic neuropathy: a position statement by the American Diabetes Association","volume":"40","author":"Pop-Busui","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.autneu.2020.102722_bb0270","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2337\/dc08-1406","article-title":"Noninvasive evaluation of neural impairment in subjects with impaired glucose tolerance","volume":"32","author":"Putz","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.autneu.2020.102722_bb0275","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/dme.12111","article-title":"Autonomic dysfunction and circadian blood pressure variations in people with impaired glucose tolerance","volume":"30","author":"Putz","year":"2013","journal-title":"Diabet. Med."},{"key":"10.1016\/j.autneu.2020.102722_bb0280","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1053\/euhj.2001.3113","article-title":"Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose","volume":"23","author":"Qiao","year":"2002","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.autneu.2020.102722_bb0285","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1590\/S0004-282X1997000500005","article-title":"Autonomic neuropathy in patients with impaired glucose tolerance","volume":"55","author":"Rezende","year":"1997","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.autneu.2020.102722_bb0290","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1212\/01.CON.0000455884.29545.d2","article-title":"Diabetic neuropathies","volume":"20","author":"Russell","year":"2014","journal-title":"Continuum Minneap. Minn."},{"key":"10.1016\/j.autneu.2020.102722_bb0295","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2337\/diacare.28.3.668","article-title":"Diabetes, glucose, insulin, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study","volume":"28","author":"Schroeder","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.autneu.2020.102722_bb0300","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0002-9149(00)00920-6","article-title":"Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study)","volume":"86","author":"Singh","year":"2000","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.autneu.2020.102722_bb0305","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.2337\/diacare.24.8.1448","article-title":"Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy","volume":"24","author":"Singleton","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.autneu.2020.102722_bb0310","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/mus.1136","article-title":"Painful sensory polyneuropathy associated with impaired glucose tolerance","volume":"24","author":"Singleton","year":"2001","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autneu.2020.102722_bb0315","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.2337\/diabetes.52.12.2867","article-title":"Microvascular complications of impaired glucose tolerance","volume":"52","author":"Singleton","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.autneu.2020.102722_bb0320","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.mayocp.2012.10.013","article-title":"COMPASS 31: a refined and abbreviated Composite Autonomic Symptom Score","volume":"87","author":"Sletten","year":"2012","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.autneu.2020.102722_bb0325","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1212\/WNL.57.9.1701","article-title":"Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy","volume":"57","author":"Smith","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.autneu.2020.102722_bb0330","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.2337\/dc06-0224","article-title":"Lifestyle intervention for prediabetic neuropathy","volume":"29","author":"Smith","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.autneu.2020.102722_bb0335","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4093\/dmj.2018.0259","article-title":"Update on the impact, diagnosis and management of cardiovascular autonomic neuropathy in diabetes: what is defined, what is new, and what is unmet","volume":"43","author":"Spallone","year":"2019","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.autneu.2020.102722_bb0340","article-title":"Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management","volume":"10","author":"Spallone","year":"2011","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.autneu.2020.102722_bb0345","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1464-5491.2007.02163.x","article-title":"The relationship of heart rate and heart rate variability to non-diabetic fasting glucose levels and the metabolic syndrome: the Cardiovascular Health Study","volume":"24","author":"Stein","year":"2007","journal-title":"Diabet. Med."},{"key":"10.1016\/j.autneu.2020.102722_bb0350","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.2337\/db12-0138","article-title":"Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects","volume":"61","author":"Straznicky","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.autneu.2020.102722_bb0355","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1212\/WNL.60.1.108","article-title":"The spectrum of neuropathy in diabetes and impaired glucose tolerance","volume":"60","author":"Sumner","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.autneu.2020.102722_bb0360","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.2337\/dc10-1303","article-title":"Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments","volume":"33","author":"Tesfaye","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.autneu.2020.102722_bb0365","doi-asserted-by":"crossref","first-page":"308","DOI":"10.2337\/diab.45.3.308","article-title":"Occurrence, predictors and clinical significance of autonomic neuropathy in NIDDM","volume":"45","author":"Toyry","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.autneu.2020.102722_bb0370","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1464-5491.1993.tb01999.x","article-title":"Effect of metabolic control on autonomic function in obese patients with newly diagnosed type 2 diabetes","volume":"10","author":"Vanninen","year":"1993","journal-title":"Diabet. Med."},{"key":"10.1016\/j.autneu.2020.102722_bb0375","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/CIRCULATIONAHA.106.634949","article-title":"Diabetic cardiovascular autonomic neuropathy","volume":"115","author":"Vinik","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.autneu.2020.102722_bb0380","doi-asserted-by":"crossref","first-page":"826","DOI":"10.2337\/diacare.23.6.826","article-title":"Is there a glycemic threshold for impaired autonomic control?","volume":"23","author":"Watkins","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.autneu.2020.102722_bb0385","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1210\/jc.2006-2175","article-title":"Epidemiological evidence of altered cardiac autonomic function in subjects with impaired glucose tolerance but not isolated impaired fasting glucose","volume":"92","author":"Wu","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.autneu.2020.102722_bb0390","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.metabol.2010.04.011","article-title":"Alpha-lipoic acid can improve endothelial dysfunction in subjects with impaired fasting glucose","volume":"60","author":"Xiang","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.autneu.2020.102722_bb0395","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/BF00408358","article-title":"The natural history of somatosensory and autonomic nerve dysfunction in relation to glycaemic control during the first 5 years after diagnosis of type 1 (insulin-dependent) diabetes mellitus","volume":"34","author":"Ziegler","year":"1991","journal-title":"Diabetologia"},{"key":"10.1016\/j.autneu.2020.102722_bb0400","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1526-4637.2008.00555.x","article-title":"Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: the MONICA\/KORA Augsburg Surveys S2 and S3","volume":"10","author":"Ziegler","year":"2009","journal-title":"Pain Med."},{"key":"10.1016\/j.autneu.2020.102722_bb0405","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1007\/s00125-015-3534-7","article-title":"Increased prevalence of cardiac autonomic dysfunction at different degrees of glucose intolerance in the general population: the KORA S4 survey","volume":"58","author":"Ziegler","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.autneu.2020.102722_bb0410","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jdiacomp.2015.10.018","article-title":"Predictors of improvement and progression of diabetic polyneuropathy following treatment with alpha-lipoic acid for 4 years in the NATHAN 1 trial","volume":"30","author":"Ziegler","year":"2016","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.autneu.2020.102722_bb0415","series-title":"Neurology Medlink: The Information Resource for Clinical Neurology","article-title":"Acute autonomic neuropathies","author":"Zilliox","year":"2011"},{"key":"10.1016\/j.autneu.2020.102722_bb0420","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11940-011-0113-1","article-title":"Treatment of diabetic sensory polyneuropathy","volume":"13","author":"Zilliox","year":"2011","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.autneu.2020.102722_bb0425","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10286-019-00607-x","article-title":"Physical activity and dietary interventions in diabetic neuropathy","volume":"29","author":"Zilliox","year":"2019","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.autneu.2020.102722_bb0430","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1212\/WNL.0b013e3182120147","article-title":"Assessing autonomic dysfunction in early diabetic neuropathy: the Survey of Autonomic Symptoms","volume":"76","author":"Zilliox","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.autneu.2020.102722_bb0435","article-title":"Clinical neuropathy scales in neuropathy associated with impaired glucose tolerance","volume":"10","author":"Zilliox","year":"2015","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.autneu.2020.102722_bb0440","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fneur.2018.00154","article-title":"Autonomic neuropathy-a prospective cohort study of symptoms and E\/I ratio in normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes","volume":"9","author":"Zimmerman","year":"2018","journal-title":"Front. Neurol."}],"container-title":["Autonomic Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1566070220301569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1566070220301569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T12:14:52Z","timestamp":1761567292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1566070220301569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":88,"alternative-id":["S1566070220301569"],"URL":"https:\/\/doi.org\/10.1016\/j.autneu.2020.102722","relation":{},"ISSN":["1566-0702"],"issn-type":[{"value":"1566-0702","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is there cardiac autonomic neuropathy in prediabetes?","name":"articletitle","label":"Article Title"},{"value":"Autonomic Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autneu.2020.102722","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102722"}}